Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
Radiology
|
December 13, 2017
<sup>18</sup>F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model
Xifu Wang, Zhanliang Su, Tianchu Lyu, et al.
Journal for Immunotherapy of Cancer
|
February 22, 2024
First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1%: results from a multicenter, open-label, phase 2 trial
Shengxiang Ren, Xicheng Wang, Bao-Hui Han, et al.
International Journal of Cancer
|
April 3, 2016
Early sorafenib-related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients
Yan Zhao, Hailiang Li, Wei Bai, et al.
Cancer Immunology, Immunotherapy : CII
|
May 10, 2024
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study
Shengxiang Ren, Anwen Xiong, Jia Yu, et al.
Advances in Therapy
|
May 23, 2026
First-Line Pembrolizumab Plus Chemotherapy for Advanced Biliary Tract Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-966 Study
Zhenggang Ren, Tingbo Liang, Shanzhi Gu, et al.
Journal of Hepatology
|
March 28, 2025
Health-related quality of life in participants with advanced biliary tract cancer from the randomized phase III KEYNOTE-966 study
Changhoon Yoo, Makoto Ueno, Heinz-Josef Klümpen, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
July 26, 2017
[Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors (2017 Edition)]
Xin Ye, Weijun Fan, Hui Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2025
Porustobart (HBM4003) plus toripalimab as second-line therapy in patients with advanced hepatocellular carcinoma: a multicenter, open-label, phase I study
Ningning Zhang, Tian Liu, Ming Luo, et al.
Scientific Reports
|
April 28, 2024
Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study
Xiaoshi Zhang, Xiaodong Zhu, Jianhong Zhong, et al.
Journal of Cancer Research and Therapeutics
|
July 5, 2018
Expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition)
Xin Ye, Weijun Fan, Hui Wang, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
Radiology
|
December 13, 2017
<sup>18</sup>F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model
Xifu Wang, Zhanliang Su, Tianchu Lyu, et al.
Journal for Immunotherapy of Cancer
|
February 22, 2024
First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1%: results from a multicenter, open-label, phase 2 trial
Shengxiang Ren, Xicheng Wang, Bao-Hui Han, et al.
International Journal of Cancer
|
April 3, 2016
Early sorafenib-related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients
Yan Zhao, Hailiang Li, Wei Bai, et al.
Cancer Immunology, Immunotherapy : CII
|
May 10, 2024
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study
Shengxiang Ren, Anwen Xiong, Jia Yu, et al.
Advances in Therapy
|
May 23, 2026
First-Line Pembrolizumab Plus Chemotherapy for Advanced Biliary Tract Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-966 Study
Zhenggang Ren, Tingbo Liang, Shanzhi Gu, et al.
Journal of Hepatology
|
March 28, 2025
Health-related quality of life in participants with advanced biliary tract cancer from the randomized phase III KEYNOTE-966 study
Changhoon Yoo, Makoto Ueno, Heinz-Josef Klümpen, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
July 26, 2017
[Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors (2017 Edition)]
Xin Ye, Weijun Fan, Hui Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2025
Porustobart (HBM4003) plus toripalimab as second-line therapy in patients with advanced hepatocellular carcinoma: a multicenter, open-label, phase I study
Ningning Zhang, Tian Liu, Ming Luo, et al.
Scientific Reports
|
April 28, 2024
Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study
Xiaoshi Zhang, Xiaodong Zhu, Jianhong Zhong, et al.
Journal of Cancer Research and Therapeutics
|
July 5, 2018
Expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition)
Xin Ye, Weijun Fan, Hui Wang, et al.
Page
of 8